Documentation Centre

 

 

  of 6393 Next page

Go to page: of

Screenshot Date Categories Title Author Format
C-reactive protein in atherosclerosis - A risk marker but not a causal factor? A 13-year population-based longitudinal study: The Tromsø study. Atherosclerosis. 2017;263:293-300 November 23, 2017 C-reactive protein in atherosclerosis - A risk marker but not a causal factor? A 13-year population-based longitudinal study: The Tromsø study. Atherosclerosis. 2017;263:293-300 Eltoft A, Arntzen KA, Hansen JB, Wilsgaard T, Mathiesen EB, Johnsen SH Key Publications
Associations of dairy intake with incident prediabetes or diabetes in middle-aged adults vary by both dairy type and glycemic status. J Nutr. 2017;147:1764-1775 November 23, 2017 Associations of dairy intake with incident prediabetes or diabetes in middle-aged adults vary by both dairy type and glycemic status. J Nutr. 2017;147:1764-1775 Hruby A, Ma J, Rogers G, Meigs JB, Jacques PF Key Publications
Lipoprotein(a): the common, likely causal, yet elusive risk factor for cardiovascular disease. J Lipid Res. 2017;58:1731-1732 November 23, 2017 Lipoprotein(a): the common, likely causal, yet elusive risk factor for cardiovascular disease. J Lipid Res. 2017;58:1731-1732 Kamstrup PR Key Publications
A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms. J Lipid Res. 2017;58:1834-1844. November 23, 2017 A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms. J Lipid Res. 2017;58:1834-1844. Mack S, Coassin S, Rueedi R, Yousri NA, Seppälä I, Gieger C, Schönherr S et al. Key Publications
High-density lipoprotein cholesterol levels are associated with coronary severity but not with outcomes in new-onset patients with stable coronary artery disease. Atherosclerosis. 2017;263:104-111 November 22, 2017 High-density lipoprotein cholesterol levels are associated with coronary severity but not with outcomes in new-onset patients with stable coronary artery disease. Atherosclerosis. 2017;263:104-111 Liu HH, Guo YL, Wu NQ, Zhu CG, Gao Y, Qing P, Li S, Zhao X, Zhang Y, Sun D, Liu G, Dong Q, Li JJ Key Publications
High-density lipoprotein cholesterol levels are associated with coronary severity but not with outcomes in new-onset patients with stable coronary artery disease. Atherosclerosis. 2017;263:104-111 November 22, 2017 High-density lipoprotein cholesterol levels are associated with coronary severity but not with outcomes in new-onset patients with stable coronary artery disease. Atherosclerosis. 2017;263:104-111 Liu HH, Guo YL, Wu NQ, Zhu CG, Gao Y, Qing P, Li S, Zhao X, Zhang Y, Sun D, Liu G, Dong Q, Li JJ Key Publications
Sex-specific clustering of metabolic risk factors and their association with incident cardiovascular diseases: A population-based prospective study. Atherosclerosis. 2017;263:249-256 November 22, 2017 Sex-specific clustering of metabolic risk factors and their association with incident cardiovascular diseases: A population-based prospective study. Atherosclerosis. 2017;263:249-256 Ramezankhani A, Azizi F, Hadaegh F, Eskandari F Key Publications
Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN. Atherosclerosis. 2017;263:137-144 November 22, 2017 Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN. Atherosclerosis. 2017;263:137-144 Puri R, Ballantyne CM, Hoogeveen RC, Shao M, Barter P, Libby P, Chapman MJ, Erbel R, Arsenault BJ, Raichlen JS, Nissen SE, Nicholls SJ Key Publications
Effects of repeated yearly exposure to exercise-training on blood pressure and metabolic syndrome evolution. J Hypertens. 2017;35:1992-1999 November 21, 2017 Effects of repeated yearly exposure to exercise-training on blood pressure and metabolic syndrome evolution. J Hypertens. 2017;35:1992-1999 Morales-Palomo F, Ramirez-Jimenez M, Ortega JF, Lopez-Galindo PL, Fernandez-Martin J, Mora-Rodriguez R Key Publications
Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention. Atherosclerosis. 2017;263:343-351 November 21, 2017 Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention. Atherosclerosis. 2017;263:343-351 Masoudkabir F, Sarrafzadegan N, Gotay C, Ignaszewski A, Krahn AD, Davis MK, Franco C, Mani A Key Publications

  of 6393 Next page

Go to page: of